-
Gilead, Bristol-Myers Declare Direct Buyers Antitrust Suit Far Too Late Gilead Sciences and Bristol-Myers Squibb urged A california federal judge Thursday to nix direct purchasers’ claims alleging the pharmaceutical businesses involved with anti-competitive conduct to block generic competition and keep HIV medicine rates artificially high, arguing the matches ought to be delivered to arbitration or trashed as time-barred. Bing Defeats ‘Loot Box’ Child Gambling …
Share
Astro for WordPress